SCHEDULE 13G/AAccepted May 14, 4:09 PM ET
Avalo Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
4:09 PM
May 14, 2026
Filed
May 14, 2026
Documents
1
Size
9.3 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.